0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Publications

Back Home

Epidemiology and Demography


880 results

Sub-Saharan Africa's Contribution to Clinical Trials in International Acute Coronary Syndromes and Heart Failure Guidelines.Hudson JA, Sanga L, Jobe M, Etyang AO, McAllister D, Perel P, Shah AS, Ogola EN
JACC Adv, (2024). 3:101383

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.Lugano D, Kutima B, Kimani M, Sigilai A, Gitonga J, Karani A, Akech D, Karia B, Ziraba AK, Maina A, Lambisia A, Omuoyo D, Mugo D, Lucinde R, Owuor S, Konyino G, Newman J, Bailey D, Nduati E, Githinji G, Agoti CN, Bejon P, Scott JAG, Agweyu A, Kagucia W, Warimwe GM, Sande C, Ochola-Oyier LI, Nyagwange J
BMC Infect Dis, (2024). 24:1474

Malaria prophylaxis in sickle cell anaemia: some answers, more questions.Williams TN, Ware RE
Lancet Infect Dis, (2024). 24:S1473-3099

Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.Garcia Quesada M, Peterson ME, Bennett JC, Hayford K, Zeger SL, Yang Y, Hetrich MK, Feikin DR, Cohen AL, von Gottberg A, van der Linden M, van Sorge NM, de Oliveira LH, de Miguel S, Yildirim I, Vestrheim DF, Verani JR, Varon E, Valentiner-Branth P, Tzanakaki G, Sinkovec Zorko N, Setchanova LP, Serhan F, Scott KJ, Scott JA, Savulescu C, Savrasova L, Reyburn R, Oishi K, Nuorti JP, Napoli D, Mwenda JM, Munoz-Almagro C, Morfeldt E, McMahon K, McGeer A, Mad'arova L, Mackenzie GA, Eugenia Leon M, Ladhani SN, Kristinsson KG, Kozakova J, Kleynhans J, Klein NP, Kellner JD, Jayasinghe S, Ho PL, Hilty M, Harker-Jones MA, Hammitt LL, Grgic-Vitek M, Gilkison C, Gierke R, French N, Diawara I, Desmet S, De Wals P, Dalby T, Dagan R, Corcoran M, Colzani E, Chanto Chacon G, Castilla J, Camilli R, Ang M, Ampofo K, Almeida SCG, Alarcon P, O'Brien KL, Deloria Knoll M, Pserenade Team
Lancet Infect Dis, (2024). 24:445-456

Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis.Bennett JC, Deloria Knoll M, Kagucia EW, Garcia Quesada M, Zeger SL, Hetrich MK, Yang Y, Herbert C, Ogyu A, Cohen AL, Yildirim I, Winje BA, von Gottberg A, Viriot D, van der Linden M, Valentiner-Branth P, Suga S, Steens A, Skoczynska A, Sinkovec Zorko N, Scott JA, Savulescu C, Savrasova L, Sanz JC, Russell F, Ricketson LJ, Puentes R, Nuorti JP, Mereckiene J, McMahon K, McGeer A, Mad'arova L, Mackenzie GA, MacDonald L, Lepp T, Ladhani SN, Kristinsson KG, Kozakova J, Klein NP, Jayasinghe S, Ho PL, Hilty M, Heyderman RS, Hasanuzzaman M, Hammitt LL, Guevara M, Grgic-Vitek M, Gierke R, Georgakopoulou T, Galloway Y, Diawara I, Desmet S, De Wals P, Dagan R, Colzani E, Cohen C, Ciruela P, Chuluunbat U, Chan G, Camilli R, Bruce MG, Brandileone MC, Bigogo G, Ampofo K, O'Brien KL, Feikin DR, Hayford K, Pserenade Team
Lancet Infect Dis, (2024). 25:457-470

Contribution of malnutrition to infant and child deaths in Sub-Saharan Africa and South Asia.Madewell ZJ, Keita AM, Das PM, Mehta A, Akelo V, Oluoch OB, Omore R, Onyango D, Sagam CK, Cain CJ, Chukwuegbo C, Kaluma E, Luke R, Ogbuanu IU, Bassat Q, Kincardett M, Mandomando I, Rakislova N, Varo R, Xerinda EG, Dangor Z, du Toit J, Lala SG, Madhi SA, Mahtab S, Breines MR, Degefa K, Heluf H, Madrid L, Scott JAG, Sow SO, Tapia MD, El Arifeen S, Gurley ES, Hossain MZ, Islam KM, Rahman A, Mutevedzi PC, Whitney CG, Blau DM, Suchdev PS, Kotloff KL
BMJ Glob Health, (2024). 9:

Breastfeeding mothers in DR Congo should have access to the mpox vaccine.Hombach J, Lewis R, Holten JV, Scott JA, Neuzil KM
Lancet Glob Health, (2024). 12:e1932

Infections in sickle cell disease.Scourfield LEA, Nardo-Marino A, Williams TN, Rees DC
Haematologica, (2024). 110:546-561

Azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a phase II randomised controlled trial.Connon R, Olupot-Olupot P, Pistorius AMA, Okiror W, Ssenyondo T, Muhindo R, Uyoga S, Mpoya A, Williams TN, Gibb DM, Walker AS, Ter Heine R, George EC, Maitland K
BMC Med, (2024). 22:516

Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic.Lucinde RK, Gathuri H, Isaaka L, Ogero M, Mumelo L, Kimego D, Mbevi G, Wanyama C, Otieno EO, Mwakio S, Saisi M, Isinde E, Oginga IN, Wachira A, Manuthu E, Kariuki H, Nyikuli J, Wekesa C, Otedo A, Bosire H, Okoth SB, Ongalo W, Mukabi D, Lusamba W, Muthui B, Adembesa I, Mithi C, Sood M, Ahmed N, Gituma B, Giabe M, Omondi C, Aman R, Amoth P, Kasera K, Were F, Nganga W, Berkley JA, Tsofa B, Mwangangi J, Bejon P, Barasa E, English M, Scott JAG, Akech S, Kagucia EW, Agweyu A, Etyang AO
BMC Infect Dis, (2024). 24:1246

Recommendations for Using Health Service Coverage Cascades to Measure Effective Coverage for Maternal, Newborn, Child, and Adolescent Health Services or Interventions.Strong K, Konstantinou G, Agweyu A, Diaz T, Jackson D, Kim M, Kubota S, Leslie H, Lazzerini M, Marchant T, Munos M, Muzigaba M, Quach A, Sheffel A, Yaqub N Jr
Glob Health Sci Pract, (2024). 12:e2400158

Recommendations for Using Health Service Coverage Cascades to Measure Effective Coverage for Maternal, Newborn, Child, and Adolescent Health Services or Interventions.Strong K, Konstantinou G, Agweyu A, Diaz T, Jackson D, Kim M, Kubota S, Leslie H, Lazzerini M, Marchant T, Munos M, Muzigaba M, Quach A, Sheffel A, Yaqub NJr
Glob Health Sci Pract, (2024). 12:e2400158

Epidemiology of human metapneumovirus among children with severe or very severe pneumonia in high pneumonia burden settings: the PERCH study experience.Miyakawa R, Zhang H, Brooks WA, Prosperi C, Baggett HC, Feikin DR, Hammitt LL, Howie SRC, Kotloff KL, Levine OS, Madhi SA, Murdoch DR, O'Brien KL, Scott JAG, Thea DM, Antonio M, Awori JO, Bunthi C, Driscoll AJ, Ebruke B, Fancourt NS, Higdon MM, Karron RA, Moore DP, Morpeth SC, Mulindwa JM, Park DE, Rahman MZ, Rahman M, Salaudeen RA, Sawatwong P, Seidenberg P, Sow SO, Tapia MD, Knoll MD
Clin Microbiol Infect, (2024). S1198-743X:00505-6

Inno4Vac Workshop Report Part 2: RSV-Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK.Waldock J, Cox RJ, Engelhardt OG, Ascough S, Osterhaus A, Rimmelzwaan GF, Ludlow M, Tregoning JS, McDonald JU, Buchholz UJ, Jeeninga RE, Sande C, Chiu C
Influenza Other Respir Viruses, (2024). 18:e70013

Inpatient and postdischarge mortality among children with anaemia and malaria parasitaemia in Kenya: a cohort study.Ngari M, Mwangome M, Ouma N, Nyaguara A, Mturi N, Obiero C, Kamau A, Walson JL, Iversen PO, Maitland K, Snow RW, Berkley J
BMJ Glob Health, (2024). 9:

Local patterns of spread of influenza A H3N2 virus in coastal Kenya over a 1-year period revealed through virus sequence data.Owuor DC, Ngoi JM, Nyasimi FM, Murunga N, Nyiro JU, Chaves SS, Nokes DJ, Agoti CN
Sci Rep, (2024). 14:23426

Is fat mass a better predictor of 6-month survival than muscle mass among African children aged 6-59 months with severe pneumonia?.Nalwanga D, Musiime V, Kiguli S, Olupot-Olupot P, Alaroker F, Opoka R, Tagoola A, Mnjalla H, Mogaka C, Nabawanuka E, Giallongo E, Karamagi C, Briend A, Maitland K
BMC Nutr, (2024). 10:130

Spatio-temporal distribution of rhinovirus types in Kenya: a retrospective analysis, 2014.Morobe JM, Kamau E, Luka MM, Murunga N, Lewa C, Mutunga M, Bigogo G, Otieno N, Nyawanda B, Onyango C, Nokes DJ, Agoti CN, Munywoki PK
Sci Rep, (2024). 14:22298

Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial.Gallagher KE, Lucinde R, Bottomley C, Kaniu M, Suaad B, Mutahi M, Mwalekwa L, Ragab S, Twi-Yeboah L, Berkley JA, Hamaluba M, Karani A, Shangala J, Otiende M, Gardiner E, Mugo D, Smith PG, Tabu C, Were F, Goldblatt D, Scott JAG
N Engl J Med, (2024). 391:2003-2013

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.Schilling WHK, Mukaka M, Callery JJ, Llewelyn MJ, Cruz CV, Dhorda M, Ngernseng T, Waithira N, Ekkapongpisit M, Watson JA, Chandna A, Nelwan EJ, Hamers RL, Etyang A, Beg MA, Sow S, Yavo W, Allabi AC, Basnyat B, Sharma SK, Amofa-Sekyi M, Yonga P, Adler A, Yuentrakul P, Cope T, Thaipadungpanit J, Rienpradub P, Imwong M, Abdad MY, Blacksell SD, Tarning J, Goudjo FF, Dossou AD, Konat�-Tour� A, Assi SB, Ouffou� K, Nasronudin N, Rachman BE, Romadhon PZ, Dewanto DD, Heryana MO, Novi T, Pasaribu AP, Mutiara M, Nasution MPR, Khairunnisa K, Dalimunthe FA, Airlangga E, Fahrezzy A, Subronto Y, Ananda NR, Rahardjani M, Rimainar A, Lucinde RK, Timbwa M, Onyango OE, Agutu C, Akech S, Hamaluba M, Kipyego J, Ngachi O, Haidara FC, Traor� OY, Diarra F, Khanal B, Dahal P, Shrestha S, Rijal S, Kabore Y, Adehossi E, Guindo O, Qamar FN, Kazi AM, Woodrow CJ, Laird S, Cheeba M, Ayles H, Cheah PY, Taylor WRJ, Batty EM, Chotivanich K, Pukrittayakamee S, Phumratanaprapin W, von Seidlein L, Dondorp A, Day NPJ, White NJ
PLoS Med, (2024). 21:e1004428